Stocks
Funds
Screener
Sectors
Watchlists
LFVN

LFVN - Lifevantage Corp Stock Price, Fair Value and News

$5.79-0.16 (-2.69%)
Market Closed

71/100

LFVN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

71/100

LFVN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$8.18

Target 3M

$6.6

Target 6M

$7.09

LFVN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LFVN Price Action

Last 7 days

1.6%

Last 30 days

-7.4%

Last 90 days

-28.2%

Trailing 12 Months

-73.4%

LFVN RSI Chart

LFVN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LFVN Valuation

Market Cap

73.5M

Price/Earnings (Trailing)

7.26

Price/Sales (Trailing)

0.32

EV/EBITDA

4.07

Price/Free Cashflow

8.46

LFVN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$8.18

Target 3M

$6.6

Target 6M

$7.09

LFVN Fundamentals

LFVN Revenue

Revenue (TTM)

228.9M

Rev. Growth (Yr)

0.73%

Rev. Growth (Qtr)

-13.7%

LFVN Earnings

Earnings (TTM)

10.1M

Earnings Growth (Yr)

18.02%

Earnings Growth (Qtr)

10.01%

LFVN Profitability

EBT Margin

5.20%

Return on Equity

30.56%

Return on Assets

16.46%

Free Cashflow Yield

11.82%

LFVN Investor Care

Shares Dilution (1Y)

1.40%

Diluted EPS (TTM)

0.78

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025222.3M228.5M228.9M0
2024205.5M200.2M196.0M212.2M
2023210.1M213.4M213.0M210.9M
2022210.2M206.4M204.9M206.4M
2021224.8M220.2M218.6M211.8M
2020229.7M232.9M231.5M229.3M
2019223.8M226.0M226.6M229.7M
2018199.8M203.2M209.7M218.4M
2017201.9M199.5M193.7M194.3M
2016198.8M206.5M216.1M213.0M
2015201.1M190.3M184.1M187.8M
2014209.4M214.0M214.3M211.0M
2013201.3M208.2M206.6M204.7M
201296.6M126.2M159.0M187.1M
2011038.9M52.6M70.4M
20100000
LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.
 CEO
 WEBSITElifevantage.com
 SECTORConsumer Defensive
 INDUSTRYPackaged Foods
 EMPLOYEES248

Lifevantage Corp Frequently Asked Questions


LFVN is the stock ticker symbol of Lifevantage Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Lifevantage Corp is 73.54 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check LFVN's fair value in chart for subscribers.

The fair value guage provides a quick view whether LFVN is over valued or under valued. Whether Lifevantage Corp is cheap or expensive depends on the assumptions which impact Lifevantage Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LFVN.

As of Wed Jan 28 2026, LFVN's PE ratio (Price to Earnings) is 7.26 and Price to Sales (PS) ratio is 0.32. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LFVN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Lifevantage Corp has provided -0.036 (multiply by 100 for percentage) rate of return.